$SUJA

Suja Defies Grocery Slowdown With Double-Digit Sales Growth in Q2

Suja Life, Inc. (Nasdaq: SUJA) reported Q2 net sales up 11.6% year over year to $83.9 million, citing volume growth and improved distribution. Gross profit increased 9.9% to $39.2 million, or 46.7% of sales. The company raised its 2026 outlook to $360 to $369 million net sales from $326.6 million in 2025.

Original reporting
Published Aug 6, 2026, 9:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Suja Defies Grocery Slowdown With Double-Digit Sales Growth in Q2 — source image
Decision brief

The 30-second read

$SUJABullishMed
01

Why it matters

Investors can update forward revenue models using the new 2026 range ($360-$369M) versus the prior 2025 reference ($326.6M) and assess whether Q2 momentum supports continued category share gains.

02

Market read

A guidance update tied to reported Q2 growth provides a concrete catalyst for traders monitoring small-cap packaged food demand and forward estimates.

03

What to watch

The article does not provide margin drivers beyond gross profit level, nor does it quantify operating income, cash flow, or inventory trends that could affect sustainability of the outlook.

Relevance 7/10Novelty 7/10Timing: pre-market today (published 2026-08-06 09:15 UTC)

Background

Suja Life is a packaged healthy beverage company; the article focuses on Q2 performance and an updated 2026 fiscal net sales outlook.

Company-level read

Ticker impact

$SUJABullishMedium confidence
Context

Suja Life reported Q2 net sales up 11.6% to $83.9M and raised its 2026 net sales outlook to $360-$369M.

Expected impact

Likely supportive for the stock, with upside bias if investors view the guidance as credible versus prior $326.6M baseline.

Evidence & confidence

The article discloses both a quarterly growth datapoint and a specific fiscal outlook range, which are direct inputs to valuation and forward estimates.

Market effects

Healthy beverage and grocery channel demand read-through may improve sentiment for similar packaged-food brands.

No specific regional impact described beyond general consumer adoption.

No explicit global supply or international demand details provided.

Counterpoint

Sales growth may be driven by distribution gains and volume, which can be less durable if retailer listings or promotional intensity fade.

Key entities

  • Suja Life, Inc.

    Reported Q2 net sales growth and updated its 2026 fiscal net sales outlook.

  • Maria Stipp

    CEO quoted on consumer adoption and brand momentum.

Related articles

$SUJAMed

SUJA LIFE, INC. (SUJA): Results of Operations and Financial Condition

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sujalifeq22026earningsrele.htm EX-99.1 Document Suja Life Reports Second Quarter 2026 Financial Results Net sales increased 11.6% year-over-year to $83.9 million Updates fiscal year 2026 outlook OCEANSIDE, CA, August 4, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,

$SUJAMedAI 9/10

Suja Life Reports First Quarter 2026 Financial Results

Suja Life (NASDAQ: SUJA) reported first-quarter 2026 net sales of $107.1 million, up 22.5% year over year from $87.4 million. Adjusted EBITDA rose 66.3% to $25.0 million, with margin expanding to 23.4%. Net income was $7.7 million versus a prior-year net loss. The company initiated 2026 guidance: net sales $367–$371 million and Adjusted EBITDA $70–$72 million.

$SUJAMed

Suja Life (NASDAQ:SUJA) Upgraded to “Strong-Buy” at Evercore

Evercore upgraded Suja Life (NASDAQ:SUJA) to a “strong-buy” rating in a Monday research note, according to Zacks.com. Other firms also initiated coverage: Goldman Sachs set a $31 target and a “buy,” Jefferies set a $25 target and a “buy,” and William Blair rated “outperform.” MarketBeat data show a consensus “Buy” and average target $26.67.

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.

$BWENMed

Broadwind Energy Q2 Earnings Call Highlights

Broadwind Energy (NASDAQ:BWEN) reported Q2 adjusted EBITDA margin near 19%, driven by higher capacity utilization, product mix and cost efficiencies, with management expecting margins to normalize. Q2 orders rose to over $35M and backlog increased across segments, with book-to-bill at 1.5. Cash and credit availability exceeded $40M. Guidance was not reinstated pending Abilene wind-down.

$CWCOMed

Consolidated Water Q2 Earnings Call Highlights

Consolidated Water (NASDAQ:CWCO) reported Q2 services revenue up 1% to $11.6M, helped by construction work in Colorado and California, partly offset by lower O&M after two customer contracts expired. Manufacturing revenue fell 49% to $2.7M. Gross profit was $11.0M (33% of revenue). The company received a 25-year Grand Cayman license, and noted Hawaii desalination and Florida equipment orders.